Galera Therapeutics, Reducing Toxicity & Increasing Anti-Cancer Efficacy for Patients

Innovation That Matters

Dr. Robert Beardsley, Founder and Chief Operating Officer at Galera Therapeutics, shares his company’s R&D vision and pipeline, aimed at improving treatments and outcomes for cancer patients. Recently, Galera’s lead […]

Big Ideas Yield Transformative Results for SMA Patients: A conversation with Stuart Peltz, the Founder and CEO of PTC Therapeutics

Breakthrough Therapy

Celebrate SMA Awareness with us!  Stuart Peltz (Founder and CEO, PTC Therapeutics) shares his perspectives on the dynamics of R&D in the context of the journey that led to the […]

One-Stop Cell and Gene Therapy Solutions for Global Innovators: A Conversation with David Chang, CEO of WuXi ATU

Innovation That Matters

In the past few years, the field of cell and gene therapy has witnessed major breakthroughs. It has become one of the hottest fields in the biotech industry, with the […]

WuXi AppTec: Collaborating Against COVID-19

COVID-19

WuXi AppTec is convening and working together with experts, from our company and around the world, for ongoing analysis of the COVID-19 pandemic. We are also partnering with other industry […]

TG Therapeutics’ Early Oncology Research Leading to New MS Therapeutic

Rare Disease

Disease-Modifying RNA Therapies from Recode Therapeutics Target Rare Lung Diseases

Rare Disease

Powerhouse Collaborator, MassBio’s President & CEO, Bob Coughlin Optimistically Embraces Industry Changes

Innovation That Matters

Click is Pioneering and Developing Cutting-edge Digital Therapeutics to Transform Medicine

Innovation That Matters

Vaccinex’s Cancer Research May Lead to Effective Treatment for Deadly Huntington’s Disease

Rare Disease

GeNeuro Believes its New and Unique Pathway in MS Research Can Lead to a Truly Effective Treatment

Rare Disease

Stronger Together: Steve Bates, CEO, UK BioIndustry Association Encourages a Fundamental Rethink

Innovation That Matters

Turning the Tides on Neurodegeneration the Denali Way, A Conversation with Ryan Watts, CEO.

Innovation That Matters

Advances in Rare Diseases: Hemophilia

Events

This complimentary webinar will convene leading physicians, drug developers, patients and advocates. These experts will discuss the latest advances in the development of transformative medicines for hemophilia, including gene therapy and next generation technologies.

Rare Disease Neurofibromatosis

Events

In honor of World Neurofibromatosis (NF) Awareness Month, the WuXi AppTec community is proud to join the millions around the world working to enhance our understanding of this rare disease.

Harnessing Our Collective Power: WuXi Online Forum II on COVID-19

Events

WuXi AppTec hosted the second online forum on the COVID-19 pandemic, titled “Harnessing Our Collective Power”, which attracted 2487 viewers via Zoom and 112,000 viewers via live streaming from 37 countries and regions.

LET SCIENCE LEAD: A Special Online Forum on COVID-19

Events

This 18-speaker forum created a strong platform for professionals within industry and academia to discuss the challenges seen in the global management of the COVID-19. Topics such as: diagnosis, therapeutic intervention, vaccine development and global preparedness were keenly discussed in conjunction with patient-focused solutions.

The New Healthcare Ecosystem | WuXi Healthcare Forum

Events

During Day two, we took a look at health beyond therapy alone. Tomorrow’s healthcare will go far further than prescribing drugs or performing surgery, it’s about bringing in the wider […]

Medicines for the Global Impact | WuXi Healthcare Forum

Events

The opening day agenda focused on novel medicines. We explored how science, technology, and entrepreneurship is driving a new age of geographically dispersed innovators, operating internationally to “bridge productivity” and […]

Announcing Latest Agenda for WuXi Healthcare Forum 2019

Events, WuXi News

WuXi Healthcare Forum 2019 Meeting Tomorrow’s Health Challenges March 5-6, 2019 | St. Regis Shanghai For registration details, please visit the Forum website. We are at the dawn of a […]

Announcing Distinguished Speakers for WuXi Healthcare Forum 2019

Events

WuXi Healthcare Forum 2019 Inspired by Meeting Tomorrow’s Health Challenges March 5-6, 2019 | St. Regis Shanghai Registration and full agenda, please click here. We are at the dawn of a […]

BIO 2018: Going Deep: How AI and Machine Learning Will Transform Drug Discovery

Events

In this panel discussion, we bring together leaders in machine learning and artificial intelligence in drug discovery and development to delve into the opportunities, capabilities, future trends and challenges of using AI to speed up drug discovery, decrease failure rates in drug trials, and create more affordable and better treatments for patients.

Marketing Authorization Holder System Summit

Events

The Marketing Authorization Holder System in China will expedite market access to the world’s second largest pharmaceutical economy, by allowing license holders of a drug to sell in China using a contract manufacturer.

ChinaBio® Partnering Forum 20

Events

Join us at ChinaBio® Partnering Forum 2017 May 31 – June 1, to meet hundreds of biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering in Zhuhai.

WuXi Executive Luncheon at MIXiii BIOMED 2017

Events

Date: Wednesday, May 24, 2017 Time: 1:30 PM – 3:00 PM IDT Duration: 1.5 hours To register, please contact Dana Yarden at dana_yarden@wuxiapptec.com. Join WuXi executives and distinguished guest speakers for a […]

WuXi Global Forum 2020

WuXi Global Forum

Now in its eighth year, the WuXi Global Forum at the J.P. Morgan Healthcare Conference brings together thousands of leaders to promote new thinking on a global stage as we […]

WuXi Global Forum 2019

WuXi Global Forum

Into its seventh year, WuXi Global Forum 2019 continues its tradition of bringing together thousands of leaders onsite and via live broadcasting to promote new thinking on a global stage.

WuXi Global Forum 2018

WuXi Global Forum

Now in its sixth year, WuXi Global Forum 2018 takes place during the J.P. Morgan Healthcare Conference, with industry thought leaders discussing rapid advancements and changes impacting the industry, from […]

WuXi Global Forum 2017

WuXi Global Forum

WuXi Global Forum 2017, now in its fifth year, brings together 1,000 industry leaders to find transformative models and solutions for patients, at a time when stakes are higher than […]

WuXi Global Forum 2016

WuXi Global Forum

The life science industry is entering a renewed age of innovation in 2015. Collectively, we have delivered strong results on almost every front, buoyed by breakthrough therapies and scientific advancements. […]

WuXi Global Forum 2015

WuXi Global Forum

To many, 2014 is a year of renewed energy and growth. Global partnerships at all levels are breaking down barriers to innovation, as the convergence of health and technology starts […]

WuXi Global Forum 2014

WuXi Global Forum

2013 has been a great year in the world of pharmaceutical and biotech R&D. While we are still facing mounting productivity challenges, many have come to understand that any single […]

WuXi Global Forum 2013

WuXi Global Forum

January 8, 2013 | Grand Hyatt San Francisco China is the world’s 3rd largest pharmaceutical market, 2nd largest economy, and the largest population with unmet medical needs. The “Gateway to […]

WuXi STA to Purchase Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland

WuXi News

NEW YORK & SHANGHAI — Bristol Myers Squibb (NYSE: BMY) and WuXi STA – a subsidiary of WuXi AppTec – today announced that WuXi STA has agreed to purchase Bristol […]

ViGeneron and WuXi Advanced Therapies Enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy

WuXi News

December 1, 2020 – Philadelphia, PA and Munich, Germany – ViGeneron, a gene therapy company, and WuXi Advanced Therapies Inc. (WuXi ATU), a leading Contract, Testing, Development and Manufacturing Organization (CTDMO), […]

WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-The-Art Testing Laboratory

WuXi News

The new laboratory will increase industry testing capacity for cell and gene therapies, enabling faster and more effective development, manufacturing and delivery to patients. November 18, 2020 – Philadelphia, PA […]

WuXi AppTec Reports Strong Third-Quarter 2020 Results

WuXi News

WuXi AppTec Third-Quarter 2020 ResultsRevenue Growth Accelerated to 35.4% Year-Over-Year to RMB 4,583 MillionAdjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 44.3% Year-Over-Year to RMB 958 MillionAdjusted Diluted Non-IFRS EPS Up 37.9% YoY to RMB0.40 WuXi […]

WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations

WuXi News

WuXi AppTec Second-Quarter 2020 Results Net Profit Attributable to Owners of the Company Up 111.0% YoY to RMB1,414 Millio Diluted EPS Up 110.3% YoY to RMB0.61 Adjusted Non-IFRS Net Profit Attributable […]

BIA-MHRA Regulatory Innovation Conference 2020

Industry News

WuXi AppTec Appoints Dr. David Chang as CEO of WuXi Advanced Therapies Business Unit

WuXi News

SHANGHAI and PHILADELPHIA, June 1, 2020 — WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, announced today the appointment of Dr. David Chang […]

Practical Considerations for Bringing Drug Candidates to Phase 1 Clinical Trail

Industry News

WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform

WuXi News

World-class platform will enable biotechnology companies and researchers to accelerate the development, manufacturing and release of cell and gene therapies for patients May 18, 2020 – Philadelphia, PA – WuXi […]

WuXi AppTec Reports Solid First-Quarter 2020 Results

WuXi News

Revenue Up 15.1% Year-Over-Year to RMB3,188 Million Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 10.8% Year-Over-Year to RMB576 Million Adjusted Diluted Non-IFRS EPS Up 9.4% Year-Over-Year […]

WuXi AppTec Reports Strong 2019 Annual Results

WuXi News

WuXi AppTec Reports Strong 2019 Annual Results Revenue Growth Accelerated 33.9% Year-Over-Year to RMB12,872 Million Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 38.2% Year-Over-Year to RMB2,407 […]

WuXi AppTec Wuhan Site Resumes Operation

WuXi News

SHANGHAI, March 12, 2020 – WuXi AppTec announced that the company’s Wuhan site resumed operations yesterday, in compliance with local regulations and global COVID-19 health and safety guidelines. Operations at […]